Philippe Leissner has been appointed Head of Development and Partnerships of Infectious Diseases Cluster

In this role, he will set up the ID360 Platform with all the founders and partners of IDCluster: national mapping of innovations currently under development in the fields of EID and AMR, and of the technological resources that can be mobilized to accelerate their development.

“I am honored to join IDCluster’s operational team and participate in this collaborative dynamic serving innovative projects that address the major infectious threats of our time,” explains Philippe Leissner. “Initially, I will focus my efforts on developing the ID360 Platform, which aims to become the leading platform in France for mapping advanced R&D projects, as well as expertise, resources, and technologies that can be mobilized in the fields of EID and AMR.”

Philippe graduated with a PhD in molecular biology from the University of Strasbourg and began his career at Transgene before joining bioMérieux, where he held several senior R&D positions in the fields of infectious diseases and precision medicine.

In 2016, he joined BIOASTER as Director of the Diagnostics program, where he developed numerous international collaborations with the healthcare industry, academia and NGOs. His work focuses on infectious diseases and antimicrobial resistance, both in high-income and developing countries.

Author of more than 35 scientific publications and patents, he now brings his expertise to the development of strategic partnerships to strengthen the work of the Infectious Diseases Cluster.